S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7127 +0.25%
CLOSED · 23:20 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

MLYS

Mineralys Therapeutics, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
21.10
−0.48 −2.22%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $1.9BP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$349.6MNET CASH $138.2M52W 20.30 – 47.33NEXT EARNINGS Nov 10 EST.SEC XBRL · TTM TO Invalid Date

What MLYS had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Oct 19Officer or director changeOct 16open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch MLYS. Know when insiders buy.
One email the day a filing lands. Free.